scispace - formally typeset
H

Hongming Pan

Researcher at Sir Run Run Shaw Hospital

Publications -  46
Citations -  8754

Hongming Pan is an academic researcher from Sir Run Run Shaw Hospital. The author has contributed to research in topics: Autophagy & Programmed cell death. The author has an hindex of 22, co-authored 46 publications receiving 7583 citations. Previous affiliations of Hongming Pan include Zhejiang University & University of Toronto.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment

TL;DR: Understanding the novel function of autophagy may allow us to develop a promising therapeutic strategy to enhance the effects of chemotherapy and improve clinical outcomes in the treatment of cancer patients.
Journal ArticleDOI

p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents.

TL;DR: New insights are provided into p38 and JNK MAPK pathways function in the control of the balance of autophagy and apoptosis in response to genotoxic stress that will hopefully provide prospective strategies for cancer therapy.
Journal ArticleDOI

The role of STAT3 in autophagy

TL;DR: Understanding the role of STAT3 signaling in the regulation of autophagy may provide insight into the classic autophagic model and also into cancer therapy, especially for the emerging targeted therapy, because a series of targeted agents execute antitumor activities via blockingSTAT3 signaling, which inevitably affects the autophile pathway.
Journal ArticleDOI

EGFR Tyrosine Kinase Inhibitors Activate Autophagy as a Cytoprotective Response in Human Lung Cancer Cells

TL;DR: Autophagy inhibition represents a promising approach to improve the efficacy of EGFR-TKIs in the treatment of patients with advanced non-small-cell lung cancer.